Inhibition of Myosin Light Chain Kinase Can Be Targeted for the Development of New Therapies Against HSV-1 Infection

Antiviral Therapy - United Kingdom
doi 10.3851/imp2661
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press


Related search